GutCRINE

Seed
gutcrine.dk Biotech & Healthcare
Total Funding Undisclosed
Latest Round Undisclosed Seed
Last Announced Jun 12, 2023
Investors Undisclosed
Decision Makers 2 Verified

About GutCRINE

"Changing the paradigm for prevention and treatment of cardio-metabolic disorders by pioneering the first-of-its-kind pharma­biotics derived from gut micro­biome hormone synthesis"

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website gutcrine.dk
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Seed announced

    fundraisingfox.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for GutCRINE.

Funding History

1 Round
Seed · Jun 12, 2023

Founders & Leadership

2

Oluf Borbye Pedersen

CSO, Co-founder

Work email & phone locked Unlock →

Yong Fan

COO, Co-founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts